Virology News and Research

Latest Virology News and Research

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Recent study reveals nirmatrelvir treatment during acute COVID-19 does not lower the risk of post-acute COVID-19 symptoms, nor is it associated with symptomatic rebound.

8 Jan 2024

SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood, which explains why this variant did not cause a widespread surge as previously feared.

8 Jan 2024

Researchers harness the power of AI to enhance assessment of the heart's right ventricle

In a milestone study, researchers from the Icahn School of Medicine at Mount Sinai have harnessed the power of artificial intelligence (AI) to enhance the assessment of the heart's right ventricle, which sends blood to the lungs.

4 Jan 2024

Paxlovid does not reduce long COVID risk in vaccinated individuals, study finds

A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.

4 Jan 2024

"Genetic priority score" promises to revolutionize drug development

Driven by the need for a better way to prioritize targets for drug development, the Icahn School of Medicine at Mount Sinai has led the development of a novel "genetic priority score" (GPS) that will integrate various types of human genetic data into a single easy-to-interpret score.

3 Jan 2024

Brain receptor discovery opens door to new therapies for addiction and mental health

Researchers at the Icahn School of Medicine at Mount Sinai have uncovered insights into the potential mechanism of action of the antipsychotic medication asenapine, a possible therapeutic target for substance use and neuropsychiatric disorders.

2 Jan 2024

Unraveling nuanced roles of JAK inhibitors in inflammation

Researchers at the Icahn School of Medicine at Mount Sinai have gained a deeper understanding of the nuanced roles of JAK inhibitors, or modulators, in inflammation across various cell types and tissues.

21 Dec 2023

New statistical technique improves disease prediction for people of African descent

A team of scientists from Icahn School of Medicine at Mount Sinai has developed a groundbreaking statistical technique, "BridgePRS," to enhance disease prediction in people of non-European ancestry, particularly those of African descent.

20 Dec 2023

€7.4M EU grant boosts development of vaccines against Marburg viruses

International research consortium receives highly endowed Horizon Europe funding for the development of vaccines against Marburg viruses.

18 Dec 2023

Experts from leading institutions launch Pandemic Research Alliance for collaborative virus defense

World-renowned professors from six leading institutions in four countries launched the Pandemic Research Alliance (PRA) today (4 December) to drive concerted research into respiratory viruses from animals to humans, improved surveillance, and new solutions to better manage the next pandemic.

17 Dec 2023

$9M awarded to study HIV and substance use at intersection of vulnerable populations

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) received an annual award for $3 million funded by the NIH Office of AIDS Research.

15 Dec 2023

Novel immunization strategies can markedly increase mucosal immunity in nonhuman primates

The global COVID-19 vaccination campaign saved an estimated 20 million lives. However, while current COVID-19 vaccines provide protection against developing severe disease, they do little to prevent infection and transmission.

15 Dec 2023

Alzheimer's may worsen COVID-19 outcomes via olfactory mucosa changes

A new study identifies alterations in the transcriptomic signatures in human olfactory mucosal cells of individuals with Alzheimer's disease following SARS-CoV-2 infection, potentially contributing to exacerbated COVID-19 outcomes.

15 Dec 2023

Mount Sinai wins $1.3 million NIH award to expand the New York City Virus Hunters program

The Icahn School of Medicine at Mount Sinai has received more than $1.3 million from the National Institute of General Medical Sciences of the National Institutes of Health (NIH) to expand the New York City Virus Hunters program.

14 Dec 2023

D-mannose could improve age-associated urinary tract dysfunction and help reduce UTIs

Aging poses a number of challenges to the body's well-being, one of the most important being an increased susceptibility to multiple diseases, including urinary tract infections (UTIs).

14 Dec 2023

Novel machine learning tool predicts gain- and loss-of-function variants across the genome

In a novel study, researchers from the Icahn School of Medicine at Mount Sinai introduced LoGoFunc, an advanced computational tool that predicts pathogenic gain- and loss-of-function variants across the genome.

14 Dec 2023

Study suggests possible targets for the development of a vaccine against multiple sclerosis

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease in which the Epstein-Barr virus (EBV) is thought to play a role that has not yet been fully clarified.

14 Dec 2023

Bottlenecks in Nucleic Acid Extraction: A Multi-Industrial approach with HiMedia Labs

An interview with Dr. Rajas Warke, Director of Molecular Biology and virology at HiMedia Labs.

From Himedia Laboratories Private Limited 12 Dec 2023

Study reveals new mechanism by which rotavirus induces diarrhea

Rotavirus causes gastroenteritis, a condition that includes diarrhea, deficient nutrient absorption and weight loss. Severe cases result in approximately 128,000 deaths annually in infants and children worldwide.

11 Dec 2023

UMSOM receives $29 million research award to improve health outcomes in people who inject opioid drugs

University of Maryland School of Medicine Dean Mark T. Gladwin, MD, announced today that the school will receive a $29 million research award over four years from the National Institutes of Health to lead a multicenter trial that aims to improve health outcomes in people who inject opioid drugs and are hospitalized with infectious complications of their drug use.

11 Dec 2023

Virology News and Research

Latest Virology News and Research

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness

Researchers harness the power of AI to enhance assessment of the heart's right ventricle

Paxlovid does not reduce long COVID risk in vaccinated individuals, study finds

"Genetic priority score" promises to revolutionize drug development

Brain receptor discovery opens door to new therapies for addiction and mental health

Unraveling nuanced roles of JAK inhibitors in inflammation

New statistical technique improves disease prediction for people of African descent

€7.4M EU grant boosts development of vaccines against Marburg viruses

Experts from leading institutions launch Pandemic Research Alliance for collaborative virus defense

$9M awarded to study HIV and substance use at intersection of vulnerable populations

Novel immunization strategies can markedly increase mucosal immunity in nonhuman primates

Alzheimer's may worsen COVID-19 outcomes via olfactory mucosa changes

Mount Sinai wins $1.3 million NIH award to expand the New York City Virus Hunters program

D-mannose could improve age-associated urinary tract dysfunction and help reduce UTIs

Novel machine learning tool predicts gain- and loss-of-function variants across the genome

Study suggests possible targets for the development of a vaccine against multiple sclerosis

Bottlenecks in Nucleic Acid Extraction: A Multi-Industrial approach with HiMedia Labs

Study reveals new mechanism by which rotavirus induces diarrhea

UMSOM receives $29 million research award to improve health outcomes in people who inject opioid drugs

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer